•
Feb 29, 2020

Walgreens Q2 2020 Earnings Report

Reported second quarter results exceeding expectations, with sequential improvement in comparable U.S. prescription volume and retail sales.

Key Takeaways

Walgreens Boots Alliance reported a 3.7% increase in sales to $35.8 billion and an EPS of $1.07. Adjusted EPS decreased 7.3% to $1.52. The company was on track to maintain fiscal 2020 guidance before the COVID-19 pandemic.

Sales increased 3.7 percent to $35.8 billion, up 4.1 percent on a constant currency basis

Operating income decreased 18.7 percent to $1.2 billion; Adjusted operating income decreased 12.0 percent to $1.7 billion, on both a reported and constant currency basis

EPS decreased 14.0 percent to $1.07; Adjusted EPS decreased 7.3 percent to $1.52, on both a reported and constant currency basis

Company on target to deliver in excess of $1.8 billion in annual cost savings by fiscal 2022

Total Revenue
$35.8B
Previous year: $34.5B
+3.7%
EPS
$1.52
Previous year: $1.64
-7.3%
Prescriptions Filled
296.8M
Gross Profit
$7.02B
Previous year: $7.76B
-9.5%
Cash and Equivalents
$792M
Previous year: $792M
+0.0%
Free Cash Flow
$1.1B
Previous year: $412M
+167.0%
Total Assets
$90B
Previous year: $70.4B
+27.8%

Walgreens

Walgreens

Walgreens Revenue by Segment

Forward Guidance

Prior to the COVID-19 pandemic, the company was on track to maintain its guidance for full-year fiscal 2020, of roughly flat growth in adjusted EPS, at constant currency rates, with a range of plus or minus 3 percent.

Revenue & Expenses

Visualization of income flow from segment revenue to net income